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The neural crest gives rise to glial cells in the peripheral nervous system. Among the peripheral glia, Schwann cells form the myelin often
wrapping the peripheral axons. Compared to other crest-derived cell lineages such as neurons, the analysis of fate determination and subsequent
differentiation of Schwann cells is not well advanced, partly due to the lack of early markers of this phenotype. In this study, we have identified a
gene, uniquely expressed in avian embryo Schwann cell precursors, which encodes a novel secreted factor, designated Seraf (Schwann cell-
specific EGF-like repeat autocrine factor). Expression of Seraf andP0 delineates the earliest phase of Schwann cell differentiation. Seraf binds to
neural crest cells and Schwann cells, and affects the distribution of Schwann cells, when introduced to chicken embryos during neural crest
migration. Our results suggest an autocrine function of Seraf and provide a significant step to understand the developmental processes of
Schwann cell lineage.
D 2004 Elsevier Inc. All rights reserved.Keywords: Schwann cell; Neural crest; Peripheral nervous system; EGFIntroduction
Neural crest cells give rise to a variety of cell types,
including neurons and glia in the peripheral nervous system
(PNS; Le Douarin and Kalcheim, 1999). In the trunk of
avian and mammalian embryos, crest-derived neuroglial
progenitors migrate medially and give rise to dorsal root
ganglia, sympathetic ganglia, and Schwann cells along the
spinal nerve. These peripheral ganglia include both satellite
glial cells and neurons.
Regulatory mechanisms of fate determination and differ-
entiation of crest-derived progenitors have been studied
extensively. Both environmental cues and crest cell-intrinsic
factors appear to affect these processes (see review; Ander-
son, 1997). As for glial development, NEUREGULIN-1
(NRG1) has been shown to promote glial differentiation,0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: wakasama@mail.cc.tokohu.ac.jp (Y. Wakamatsu).proliferation, and survival (Dong et al., 1995; Leimeroth et
al., 2002; Shah et al., 1994). However, such environmental
factors do not appear to be sufficient in ganglionic locations,
where both neurons and satellite glia differentiate. In a
previous study, we showed that NOTCH-mediated lateral
inhibition is involved in this process (Wakamatsu et al.,
2000). Thus, a Notch ligand, Delta1, is presented on the
surface of neurons and activates Notch signaling in neigh-
boring cells to prevent their neuronal differentiation. Al-
though continuous activation of Notch signaling appears to
inhibit general differentiation (Wakamatsu et al., 2000),
another report showed a soluble form of Delta1 added in
culture medium promotes glial differentiation (Morrison et
al., 2000). It is still unclear what kind of glia differentiated
under these conditions.
Although there are several transcription factors that are
known to regulate neuronal differentiation in the PNS (for
review, see Anderson, 1997), there are only a few such factors
known to regulate glial differentiation in the PNS. For
example, Sox10 is expressed in early migrating crest cells
and its expression is subsequently restricted to glial cells
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mutation affects differentiation of a wide variety of neural
crest-derived cell types (Britsch et al., 2001; Dutton et al.,
2001; Kelsh and Eisen, 2000; Southard-Smith et al., 1998),
detailed analyses in cultured crest-derived cells indicate that
Sox10 is required for both survival of crest-derived cells and
their glial differentiation (Paratore et al., 2001). Krox20 and
Oct6/SCIP have been shown to regulate Schwann cell dif-
ferentiation in mammals (for review, see Jessen and Mirsky,
2002). However, the requirement of these factors appears to
be restricted in the late phase of Schwann cell maturation. In
avian embryos, Oct6 is expressed in Schwann cells at very
late stages (Levavasseur et al., 1998) and Krox20 appears to
be expressed exclusively in neurons of the PNS (YW,
unpublished observation). Other than gene regulatory pro-
teins, the earliest marker for glial cells in the PNS known to
date is P0, which encodes a cell surface protein involved in
myelination (Bhattacharyya et al., 1991). So far, there are
very fewmarkers and regulators known to be expressed in the
PNS glia and this has limited progress in this field.
In this paper, we report identification of a novel gene,
Seraf, whose expression indicates a very early segregation
of Schwann cell precursors. We show that changes in Seraf
expression delineate the early steps of Schwann cell
differentiation. Seraf encodes a secreted protein with
EGF-like repeats. We also show that Seraf acts as an
autocrine factor on Schwann cells themselves and regulates
their distribution.Experimental procedures
Experimental animals
Fertilized chicken and Japanese quail (Coturnix coturnix
japonica) eggs were obtained from the Animal Sciences
Department, Oregon State University, Corvallis, OR, and
Sendai Jun-ran, Sendai. Embryos were staged according to
Hamburger and Hamilton (1951).
Neural crest culture
An out-growth culture of quail trunk crest cells was
performed as described previously (Marusich et al., 1994;
Wakamatsu and Weston, 1997). Stages 12–14 quail neural
tubes were prepared as described previously (Glimelius and
Weston, 1981; Loring et al., 1981). Neural tube explants
were cultured in neurogenesis-permissive medium (Henion
et al., 1995; Ham’s F12 supplemented with 15% fetal
bovine serum and 4% chicken embryo extract) for 12–13
h or 3 days for AP binding assays. For Seraf expression
studies, after 20 h of neural tube outgrowth culture, neural
tubes were carefully removed and remaining crest cells were
harvested by trypsin treatment and subsequent centrifuga-
tion. Then, crest cells were replated on fibronectin-coated
dishes in Sylgard wells (10 mm diameter, 10,000 cells/well;Marusich and Weston, 1992). One day after replating, some
cultures were fixed and processed for in situ hybridization
(see below). Remaining cultures were further cultured for 2
or 4 additional days, either with or without EGF domain
fragment of NRG1 (25 ng/ml, Heregulin-h, EGF domain,
Upstate biotechnology) for in situ hybridization.
To obtain early neurogenic crest clusters and old non-
neurogenic clusters, isolated neural tubes were cultured on
agar-coated dishes for 24 and 48 h, respectively (Glimelius
and Weston, 1981; Vogel and Weston, 1988). Clusters were
carefully isolated from the neural tube explants with a sharp
tungsten needle.
Differential display RT-PCR
Total RNAs were prepared from neural crest clusters,
neural tubes, and somites with RNeasy kit (QIAGEN).
Contaminating genomic DNA was removed by a treatment
with RNase-free DNase (Ambion). cDNA was synthesized
with anchor primers (A/G/C(TX15)G) by the use of Super-
scriptII preamplification kit (Invitrogen). PCR reaction was
performed with 33P-dATP in reaction mixtures. Combina-
tions of one of the anchor primers (see above) and upstream
arbitrary primers (special 10-mer set, Operon) were used.
Amplified DNAs were separated on standard denaturing
sequence gels and exposed to X-ray films. Differentially
displayed bands of interest were excised, reamplified,
subcloned into pBluescriptII (Stratagene), and sequenced.
Step-by-step protocol is available upon request. The com-
bination of primers that resulted in an identification of Seraf
was G(Tx15)G and TGGATTGGTC (OP-26-02). Isolated
cDNA clones were used for a further analysis with whole-
mount in situ hybridization (see below).
Cloning of P0 and full-length Seraf
To obtain the whole coding sequence of Seraf, chicken
limb bud cDNA library (Nohno et al., 1992) was screened
with the quail Seraf cDNA fragment. Isolated chicken
cDNA contained single long open reading flame (GenBank
accession no. AY390351; see Fig. 1).
A cDNA fragment of quail P0 homolog was isolated
from a cDNA pool prepared from E4 quail embryos by a
standard RT-PCR. Primer sets were designed, according
to the previously published chicken sequence (Barbu,
1990).
In situ hybridization and immunological staining
In situ hybridization in whole-mount preparation and on
section was performed as described previously (Wakamatsu
and Weston, 1997). For cultured cells, cells were fixed with
4% paraformaldehyde/PBS for 10 min, washed in PBS a
few times, and dehydrated. Subsequently, cultures were
covered with 1% gelatin to prevent detachment during
following in situ procedure. In situs with quail probes in
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in quail tissues.
Immunological staining of cultured cells, cryosections, in
whole-mounts was performed as described previously
(Wakamatsu and Weston, 1997; Wakamatsu et al., 1993).
16A11 anti-Hu (mouse IgG2b; Marusich et al., 1994), 1E8
anti-P0 (mouse IgG1; Bhattacharyya et al., 1991), anti-
neurofilament M (mouse IgG2a; Wakamatsu and Weston,
1997), 7B3 (mouse IgM; Henion and Weston, 1997; Henion
et al., 2000), MEBL-1 (mouse IgG1; Kitamura et al., 1992),
and HNK1 (mouse IgM; Tucker et al., 1988) antibodies
were used as described previously. M2 anti-FLAG (mouse
IgG1, Sigma) and fluorochrome-conjugated secondary anti-
bodies (Jackson) were commercially obtained.
Construction of expression vectors
The open reading frame of Seraf cDNA was PCR-
amplified and cloned into pyDF31 for C-terminal FLAG
tagging and expression in cultured cells. A cDNA fragment
of placental alkaline phosphatase (AP) was taken from
pAPtag2 (a kind gift of Dr. Flanagan; Cheng and Flanagan,
1994; Flanagan and Leder, 1990) and inserted to pyDF31-
Seraf for C-terminal AP fusion protein expression. pEYFP-
Golgi, encoding a fusion protein of enhanced yellow fluo-
rescent protein (EYFP) and N-terminal fragment of human
beta 1, 4-galactosyltransferase (BD Biosciences Clontech),
was used to visualize Golgi apparatus.
Binding analysis of AP–Seraf
Either pAPtag4 or pyDF31-Seraf-AP (see above) was
transfected to NIH3T3 mouse fibroblast cell line and con-
ditioned media were prepared. AP activity was measured on
dot blots with AP-Star detection kit (Amersham). Live,
cultured neural crest cells and cryosections of unfixed
embryos were incubated with the conditioned medium for
1 h. After fixation with 4% paraformaldehyde in PBS for 20
min and washing in PBS, endogenous AP was heat-inacti-
vated by incubation at 65jC for 1 h. AP activity was
detected by a color reaction with NBT/BCIP substrate.
Transplantation of Cos-7 cells into embryos
Either untransfected or pyDF31-Seraf-transfected Cos-7
cells were plated on agar-coated dishes and cultured for 24
h to obtain cell aggregates. Chicken eggs were windowed
and the cell aggregates were transplanted into a newlyFig. 1. Characterization of Seraf cDNA. (a) The result of differential display RT-PC
h old crest clusters, and somites. Asterisk indicates bands that correspond to Se
hydrophilicity analysis of Seraf protein. Hydrophilic sequence at the amino-term
Seraf, Wnt inhibitory factor 1 (WIF1) in Xenopus (Hsieh et al., 1999), and Delta1
indicated with dark boxes. Amino acids only shared with two of them are indica
transfected with expression vectors of FLAG-tagged Seraf and pEYFP-Golgi. Not
indicates nuclei. (f) Secretion of Seraf-alkaline phosphatase fusion protein (Seraf–
phosphatase), or pyDF31-Seraf-AP-transfected NIH3T3 cells were blotted on a mformed somite of stage 13 embryos. Transplanted embryos
were allowed to develop for 2 days and subjected to whole-
mount in situ hybridization (see above). In this case, 3V
UTR of Seraf was used to detect only endogenous Seraf
mRNA.Results
Cloning of Seraf
To identify stage-specific and cell type-specific genes
expressed in neural crest-derived cells, we performed dif-
ferential display RT-PCR by using cultured quail neural
crest cells as sources of RNA. Caudal neural tubes, dissect-
ed from Hamburger and Hamilton stages 12–14 embryos
(Hamburger and Hamilton, 1951), were cultured, and clus-
ters of neural crest cells were harvested after 24 and 48 h of
culture on nonadhesive substrata (Glimelius and Weston,
1981; Vogel and Weston, 1988). Cells in these two cluster
populations have been shown to differ in developmental
potential since the older cluster populations lack cells with
neurogenic ability (Vogel and Weston, 1988; Wakamatsu
and Weston, 1997; Maynard et al., 2000). RNAwas purified
from young (24 h) and old (48 h) crest cell clusters, as well
as from newly formed somites and from neural tubes after
48 h of culture, and gene expression profiles were compared
(Fig. 1a, see Experimental procedures). Among the bands
displayed, one band specific to the young cell population
contained sequences homologous to chicken Slug (Neito et
al., 1994), which has been shown to be expressed in nascent
neural crest cells and appears to function in early neural
crest development (del Barrio and Nieto, 2002; La Bonne
and Bronner-Fraser, 2000; Neito et al., 1994). This result
validates the notion that gene products characteristic of
young and old crest cell populations can be distinguished
in this system.
Another band indicating the presence of abundant tem-
plate in young crest compared to old crest cell populations,
and the corresponding absence of template in somite and
neural tube cells (Fig. 1a), showed an interesting expression
pattern by in situ hybridization (see below). Using this
cDNA fragment as a probe, we screened a chicken cDNA
library and isolated a cDNA fragment containing an open
reading frame, as well as an entire 3V UTR almost identical
to the initially isolated quail fragment (Fig. 1b). Predicted
amino acid sequence revealed that the corresponding protein
possessed a hydrophobic, potential signal sequence at theR. cDNAs were prepared from neural tubes, 24-h young crest clusters, 48-
raf cDNA. (b) DNA and amino acid sequences of Seraf. (c) Hoop Wood
inus corresponds to a putative secretion signal. (d) Sequence alignment of
in chicken (Henrique et al., 1995). Amino acids identical in all of them are
ted with light boxes. (e) Anti-FLAG immunostaining of NIH3T3 cells co-
e a clear overlap of anti-FLAG staining and Golgi apparatus. DAPI staining
AP). Supernatant of mock-, pAPtag-4- (carrying secreted version of alkaline
embrane, and AP activity was detected by chemiluminescence.
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repeats (Fig. 1d). Sequence alignment indicated a significant
conservation with other EGF-repeat containing proteins,
such as Wnt inhibitory factor 1 (WIF1, Fig. 1d; Hsieh et
al., 1999), Notch ligands, such as Delta1 (Fig. 1d; Henrique
et al., 1995), and Tenascin (not shown). Based on the
expression pattern, structure, and the function, we designat-Fig. 2. Expression of Seraf mRNA in neural crest cells and glial cells in the PNS
region. A subpopulation of neural crest-derived cells is Seraf-positive. (b, c) A tr
While many HNK1-positive crest-derived cells have entered the medial migratio
transverse section of an in situed embryo shown in a at the forelimb level. DR
already differentiated (f, arrows). Seraf-positive cells are observed along the later
embryo. Seraf-positive cells are segmentally localized, but some of them are
transverse section of stage 22 trunk. HNK1-positive crest-derived cells along t
embryo. Seraf is expressed in glial cells along the cranial nerves and olfactory n
mRNA (arrowhead). (k) A high magnification view of ventro-temporal par
neurofilament-positive ciliary axons (arrows). (l –n) Seraf-expressing cells in
Esophagus level. ac, accessory nerve; dm, dermomyotome; drg, dorsal root gangl
tg, trigeminal nerve.ed this gene as Seraf (Schwann cell-specific EGF-like repeat
autocrine factor, see below).
Next, we transfected an expression vector of carboxy-
terminally FLAG-tagged Seraf into NIH3T3 cells. FLAG
immunoreactivity was then observed as accumulation of
dots in the cytoplasm of transfected cells (Fig. 1e). This
punctate staining mostly co-localized with Golgi-directed. (a) Whole-mount in situ of stage 19 embryo. A dorsal view of the trunk
ansverse section of an in situed embryo shown in a at the hind limb level.
n pathway, Seraf-positive cells remain in the MSA (arrowhead). (d– f) A
G is revealed by HNK1 staining (e), and some Hu-positive neurons have
al edge of the nascent DRG (d, arrowheads). (g) A dorsal view of stage 22
entering fore- and hind limb buds along the axonal plexus. (h and j) A
he spinal nerve co-express Seraf mRNA. (j) A lateral view of stage 22
erve. Cells along the axons from ciliary ganglia are also positive for Seraf
t of eye. Seraf-positive cells (arrowheads) are in close contact with
digestive tract is in close contact with neurofilament-positive neurites.
ia; fl, forelimb bud; hl, hind limb bud; ntm neural tube; of, olfactory nerve;
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while a minor proportion of the punctate staining was also
observed throughout the cytoplasm, possibly corresponding
to transport vesicles (data not shown). Coupled with the
putative signal sequence, the intracellular localization of
transgene-derived Seraf suggested that the protein would be
secreted. To test this idea, cells were transfected with
expression vectors of alkaline phosphatase directly fused
to signal sequence (AP) and a fusion of Seraf and alkaline
phosphatase (Seraf–AP). After transfection, alkaline phos-
phatase activity was detected in the supernatant of both AP
and Seraf–AP transfected cells, but not detected in the
supernatant of mock-transfected cultures (Fig. 1f). Taken
together, we conclude that this cell type-specific gene
encodes a novel secreted molecule expressed in neural
crest-derived cells.
Expression of Seraf mRNA in early Schwann cell precursors
To analyze the expression pattern of the identified
mRNA in neural crest development, whole-mount in situ
hybridization was performed in stages 17–24 embryos.
Initially, cells that expressed Seraf were found in a sub-
population of migrating neural crest cells in the trunk
(stage 18 at the wing level; Fig. 2a). These embryos were
sectioned and counterstained with markers such as HNK-1
for neural crest-derived cells (Figs. 2b, c), and Hu for
differentiating neurons (Figs. 2d–f). Since development
proceeds in a rostral to caudal sequence, sections at the
caudal level (b in Fig. 2a) corresponds to an earlier
developmental stage compared to sections at a more rostral
level (d in Fig. 2a). At the early developmental stage (b),
Seraf-positive cells were found in the HNK-1-positive crest
cells, residing in the migration staging area (MSA; Weston,
1991) (Figs. 2b, c). At this time, many crest-derived cells
had also dispersed on the medial migration pathway (Fig.
2c). At later developmental stages (d), when neurogenesis
had begun in the dorsal root ganglia (DRG) (Fig. 2f),
Seraf-positive cells were found on the medial pathway
(Fig. 2d), along the lateral periphery of the nascent DRG
(Fig. 2e).
At later stages of development, expression of Seraf
appeared to be restricted to the various peripheral nerves
(Figs. 2g–k), suggesting the identity of Seraf-positive cells
as Schwann cell precursors. The segmentally positioned
Seraf-positive cells in the trunk of stage 23 embryo
seemed to associate with the spinal nerve cord and these
cells expressed HNK-1 (Figs. 2h, j). In the head region,
Seraf expression was detected in cells associating with the
axons of peripheral nerve (Figs. 2j, k). For example,
neurofilament-positive axons of ciliary ganglia neurons
were in close contact with the Seraf-positive cells. These
observations suggested that Seraf-positive cells were a
subpopulation of neural crest-derived cells specified as
Schwann cell precursors. In addition, we found Seraf-
positive cells, probably enteric glia, in the embryonicgut, associating neurofilament-positive neuronal processes
(Figs. 2l–n).
To examine the Seraf expression at later stages of
development, in situ hybridization was performed on
sections of stages 24–37 embryos at the trunk level
(Fig. 3). At stage 24, Seraf-positive cells closely associ-
ated with the spinal nerves. Interestingly, Seraf expression
was not detectable in the most proximal part of the nerve
(Fig. 3a) unlike slightly younger embryos (Fig. 2h). This
region expressed high levels of P0 (Fig. 3b), a glial
differentiation marker (Bhattacharyya et al., 1991), al-
though a weaker expression of P0 was also observed in
more distal part of the nerve cord, overlapping with Seraf
expression (Figs 3a, b). As development proceeded (stage
26), Seraf expression was found in a number of cells
scattered along the spinal nerve (Fig. 3d). In neighboring
sections, strong P0 expression was detected in Schwann
precursor cells localized in the proximal part of the nerve
cord, such as the ventral nerve and dorsal nerve (Figs. 3c,
e), although weaker P0 expression was also observed in
more distal region (Fig. 3c). At stage 31, as neurofilament-
positive peripheral nerves were extended into the periph-
ery, Schwann cell precursors expressing Seraf were found
to be associating with those peripheral nerves, and more
HNK-1-positive Schwann cells in the proximal nerve no
longer expressed Seraf (Figs. 3f–i). At this stage, many
Seraf-positive cells were found in close contact with
neurofilament-positive peripheral axons within skeletal
muscle tissue (Figs. 3j, k). In stage 37 embryos, Seraf
expression was further down-regulated in the distal part of
the nerve cord and remaining Seraf expression was mostly
found in scattered Schwann cell precursors in close
contact with peripheral axons within skeletal muscle (data
not shown).
At no stage examined, was expression of Seraf detected
in satellite glia and neurons in ganglia, melanocytes in the
skin, or mesenchymal cells in the craniofacial tissues. These
expression patterns indicated that Seraf expression was
restricted to immature Schwann cell precursors, and as these
cells underwent the initial step of differentiation revealed by
the increased P0, expression of Seraf was immediately
down-regulated. This dynamic change in Seraf and P0
expression appeared to occur proximal to distal sequence,
thus, Seraf expression might be maintained in the most
distal Schwann cell precursors.
Transient expression of Seraf is stimulated by NRG1 in
culture
Spatial– temporal pattern of Seraf mRNA distribution in
different stages of embryos suggested that Seraf expression
is transient. To examine the temporal changes of Seraf
expression, cultured trunk crest cells were examined (Fig.
4). One day after replating, approximately 30% of crest cells
expressed Seraf. Three days after replating, 43% of cells
were Seraf-positive. Although the proportion of Seraf-pos-
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level of Seraf expression appeared to be down-regulated
significantly.Such a transient increase of Seraf expression was
observed more clearly when culture was exposed to
EGF-like domain fragment of NRG1 (Fig. 4). NRG1
Fig. 4. A transient expression of Seraf in cultured neural crest cells. Neural crest cells were prepared from neural tube explants, and cultured for 1, 3, and 5 days
with or without NRG1 (see Experimental procedures). Seraf expression is transiently up-regulated and further enhanced by NRG1 exposure. The graph
indicates proportions of Seraf-positive cells/total cells. To obtain each value, more than 400 cells were examined and the proportion of Seraf-positive cells was
obtained, and averages of three independent experiments were plotted. Error bars indicate standard deviation.
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Schwann cell precursors as well as promote their differ-
entiation and survival (Dong et al., 1995; Leimeroth et
al., 2002; Shah et al., 1994). Consistently, after 3 days of
culture with NRG1, the total number of cells in culture
was almost doubled, and more than 80% of cells strongly
expressed Seraf. After 5 days of culture, however, the
proportion of Seraf-positive cells declined rapidly to
52%, almost identical to the proportion cultured without
NRG1.
These observations in culture confirmed the transient,
Schwann cell precursor-restricted nature of Seraf expression
suggested by in situ studies described above (Figs. 2, 3).
Seraf protein may act as an autocrine and/or paracrine
factor
To begin to identify Seraf function, binding assays with
alkaline phosphatase fusion protein (Seraf–AP) were per-
formed in cultured neural crest cells, as well as on sectionsFig. 3. Transient Seraf expression in Schwann cell precursors. (a) A transverse sec
along the peripheral nerve. Schwann cells in the dorsal root (arrow) and ventral ro
Seraf-negative. (b) A transverse section of stage 24 embryo, stained with anti-P0 an
(arrow) and proximal part of ventral nerve (arrowhead). (c–e) Transverse sections
Schwann cells along the spinal nerve (c and e, arrowheads). P0 expression is also
detected in Schwann cells in the dorsal root (arrow) and in the proximal part of
actively dispersing Schwann cell precursors. (f – i) A transverse section of stage 3
along the neurofilament-positive spinal axons (arrows in f, g). HNK1-positive ven
staining (i). (j and k) A high magnification view of dorsal skeletal muscle of stag
axons (arrowheads). drg, dorsal root ganglia; nt, neural tube.(Fig. 5). First, trunk neural tubes were cultured, allowing
neural crest cells to emigrate and differentiate (Figs. 5a–f).
Little binding was detected when cells were incubated with
AP alone (Fig. 5a). Binding of Seraf–AP was detected both
in early migrating neural crest cells at 24 h of culture (Figs.
5b, c) and in glial cells at 3 days of culture (Fig. 5e).
Interestingly, the binding was not uniform in the neural crest
outgrowth. For example, binding was more pronounced in
the neural crest cells closer to the neural tube explant (Fig.
5c). In older explant cultures, in addition to glial cells, the
binding of Seraf–AP was detected along neurofilament-
positive axons (Figs. 5e, f), although it was not possible to
distinguish binding directly to axons and binding to pro-
cesses of glia wrapping the axons (Figs. 5e, f).
To examine further the potential binding of Seraf–AP to
axons, DRG was taken from 5-day-old chick embryos,
dissociated into single cells, and plated at low density.
Then, cultures were stained with Seraf–AP and counter-
stained with anti-neurofilament M antibody for axons, 7B3
antibody for glial processes (Henion et al., 2000), and DAPItion of stage 24 embryo. Seraf is expressed only in Schwann cell precursors
ot (arrowhead), as well as crest-derived cells in the dorsal root ganglia are
tibody. Strong P0 expression is detected in Schwann cells in the dorsal root
of stage 26 embryo. Compared to b, P0 expression expands more distally in
high in the dorsal root Schwann cells (arrow). (d) Seraf expression is not
the spinal nerve (arrowheads). Seraf-positive cells are found in scattered,
1 embryo. Seraf is strongly expressed in distally migrating Schwann cells
tral Schwann cells are Seraf-negative (arrow in h). DAPI indicates nuclear
e 31 embryo. Seraf-positive cells are in contact with neurofilament-positive
Fig. 5. Detection of Seraf binding site. (a and b) One-day culture of neural tube explant incubated with alkaline phosphatase (AP) (a) or Seraf–alkaline
phosphatase fusion (Seraf–AP) (b). (c and d) A high magnification of b, indicating Seraf binding to migrating neural crest cells (arrowhead). DAPI indicates
nuclear staining (d). (e and f) Three-day culture of neural tube explant incubated with Seraf–alkaline phosphatase fusion. Seraf binds with flat glial cells as well
as neurofilament-positive axons (arrowhead). (g– i) Seraf–AP staining of cultured DRG cells. A neurofilament (NF)-positive axon (arrowhead) is bound by
Seraf–AP (g and h). 7B3-immunoreactive glial fiber is not overlapping the axon (i). (j – l) Transverse sections of stage 28 embryo, incubated with Seraf–AP (j
and l) or AP (k). (l) High magnification of j showing Seraf–AP binding to myotome and spinal nerve. mt, mytotome; nt, neural tube; sn, spinal nerve.
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was observed in axons with little overlap of glial processes
(Figs. 5g–i).
Binding assays were also performed on sections of stage
28 embryos (Figs. 5j, l). As before, little or no binding was
detected when cells and tissues were incubated with AP
alone (Fig. 4k). Binding of Seraf–AP was detected in the
spinal nerves (Fig. 4l), as well as in the epidermis, skeletal,
and heart muscles (Fig. 5l and data not shown).These observations suggested that Schwann cell precur-
sor-derived Seraf targeted both Schwann cell precursors and
neuronal axons.
Exogenous Seraf protein alters Schwann cell distribution in
vivo
To examine the function of Seraf protein, aggregates of
Cos-7 cells transfected with a Seraf expression vector were
Y. Wakamatsu et al. / Developmental Biology 268 (2004) 162–173 171transplanted into a newly formed somite at the cervical level
of stage 12 chicken embryos and the host embryos were
allowed to develop for 2 days (stages 22 and 23). Since
Seraf–AP bound to Schwann cell precursors and also to
axons (see above), localization of Seraf-positive cells and
distribution of axonal projections were examined in whole-
mount preparations of transplanted embryos. Untransfected
Cos-7 cells had no effect on the distribution of Seraf-
positive Schwann cell precursors (10/10 samples; Fig. 6a).
In contrast, compared to the contralateral side (Fig. 6c),
dispersal of Schwann cell precursors appeared to be locally
disrupted on the transplanted, ipsilateral side of the same
host embryo (8/12 samples; Fig. 6d). Sections of these
transplanted embryos revealed that the proper distribution
of Schwann cell precursors was perturbed in the vicinity of
the implanted Cos cells (Figs. 6e–g), but not in the vicinity
of untransfected cells. In neither case was any obvious
defect found in the differentiation of other neural crest-
derived cells, based on the expression of markers, such as
neurons (Hu), glial (P0), and melanocytes (MEBL-1).Fig. 6. Exogenous Seraf alters Schwann cell distribution. Lateral views of embryos t
hybridized with Seraf 3VUTR antisense probe. Transplanted side (ipsilateral) is
Transplantation of Seraf-Cos-7 cells disrupts proper dispersal of Seraf-positive Sch
Seraf-Cos-7 transplanted embryo. A transplanted cell aggregate is indicated by an as
cells and neurofilament-positive axons is affected.Whole-mount immunostaining with anti-neurofilament an-
tibody revealed that proper projection of peripheral axons
was also marginally affected by Cos–Seraf transplantation
(4/12 embryos), while no obvious effect on axon projection
patterns was detected by a control transplantation of
untransfected Cos cells (8/8 embryos). Sections revealed
that axonal growth was perturbed on the transplanted side
(Fig. 6f), as Seraf-positive cells also failed to disperse (Fig.
6e). These results suggested that Seraf protein might mod-
ulate the migratory behavior of Schwann cells and projec-
tion of peripheral axons by binding in an auto/paracrine
fashion to their cell surfaces.Discussion
In this study, we have identified a new gene, Seraf,
which encodes a novel secreted protein with EGF-like
repeats. Seraf is initially expressed in a subpopulation of
medially migrating neural crest cells, and subsequently inransplanted with either Cos-7 cells (a) or Seraf-transfected Cos-7 cells (b–d),
shown in b and d; c indicates untransplanted side (contralateral) of d.
wann cell precursors (arrowheads in b and d). (e–g) A transverse section of
terisk. In a transplanted side, the distribution of HNK1-positive crest-derived
Y. Wakamatsu et al. / Developmental Biology 268 (2004) 162–173172cells associating with the peripheral axons. While at least
some of the premigratory cells in the dorsal neural tube and
neural crest-derived cells are multipotent (Bronner-Frasr
and Fraser, 1988; Fraser and Bronner-Fraser, 1991; Ser-
bedzija et al., 1994; Morrison et al., 1999), recent studies
revealed the early specification or fate restriction of crest-
derived cell types (Henion and Weston, 1997; Perez et al.,
1999; Wakamatsu et al., 1998,2000). The expression pat-
tern of Seraf suggests very early segregation of a Schwann
cell lineage in the neural crest development. It is notewor-
thy that Seraf expression begins in the migration staging
area (MSA; Weston, 1991) between the dorsal part of
neural tube and somite (Weston, 1991). Expression of other
early lineage markers also begins in this region. For
example, at the wing level, some neuronal cells express
Delta1 at stages 16 and 17 (Wakamatsu et al., 2000).
Melanocyte precursors express mitf at stage 19 in MSA
and subsequently disperse on the lateral migratory pathway
(Wakamatsu et al., 1998). Since Seraf is expressed in crest
cells residing in MSA at the wing level of stage 18 embryo,
Schwann cell specification may occur between neuronal-
and melanocyte-forming stages.
To date, no other Schwann cell-specific genes are
known to be expressed as early as Seraf. Furthermore,
since Seraf expression is down-regulated as P0 expression
increases, Seraf expression likely delineates an early
stages of differentiation of Schwann cells and appears
to indicate the earliest step of Schwann cell specification
identified so far. As mentioned in the introduction, NRG1
signaling is extremely important for differentiation, pro-
liferation, and survival of Schwann cells (Dong et al.,
1995; Leimeroth et al., 2002; Shah et al., 1994). Consid-
ering the robust increase of Seraf-positive cells in neural
crest culture exposed to EGF-domain of NRG1, Seraf
expression may be regulated by NRG1 signaling. Future
analyses on regulation of Seraf expression will provide
important information on the control of Schwann cell
specification.
The function of Seraf remains largely unknown. Our
binding analysis indicates that Seraf could act, at least, as an
autocrine, and/or paracrine fashion on Schwann cell pre-
cursors themselves. Consistently, exogenous Seraf disrupted
the Schwann cell precursor distribution in manipulated
embryos. It is unclear, however, whether Seraf directly
affects the migration of Schwann cell precursors, or its
association with neurites, since an axonal extension was
also affected. When migrating neural crest cells from neural
tube explants, motor axons of ventral neural tube, or sensory
axons of DRG were confronted with Seraf-transfected Cos-
7 cells in a collagen gel, no changes in cell migration or
axonal growth were detected (data not shown). Since Seraf
protein shows a significant sequence homology to Wnt-
inhibitory factor 1 (WIF1, see above), which binds to Wnt
proteins and antagonizes their function(s), the action of
Seraf may also be affected by the presence of other
molecules. Alternatively, Seraf may require post-translation-al modification(s). It has been known that the EGF-like
repeats of Notch receptor are modified by the lunatic fringe
gene product and O-fucosyltransferase (Bruckner et al.,
2000; Moloney et al., 2000; Okajima and Irvine, 2002). It
will be essential to identify modulator(s), binding partner(s),
or cellular receptor(s) to understand the function of Seraf
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